Alan J. Russell

All filings by Alan J. Russell on record concern Edgewise Therapeutics, Inc., in the capacity of senior executive. In total, 27 filings cover trades dated from 23 September 2021 to 12 August 2026.

Sales make up the whole of the open-market record (14 sales, €2.8M). Outside the open market, there are 13 option exercises. So far in 2026, the count stands at no purchases and 3 sales.

Most recently, on 14 August 2026, the filings show an option exercise in Edgewise Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.